Enteris BioPharma is a clinical-stage biopharmaceutical company that specializes in the development of oral dosage formulations for peptides and small molecule therapeutics. Utilizing its proprietary Peptelligence® and ProPerma® technologies, Enteris BioPharma enhances the solubility and permeability of challenging drug compounds, facilitating oral delivery of medications that traditionally require injection.